She noted that the Canadian researchers estimated that the flu vaccine is 55 percent effective
against influenza B viruses, which typically cause more infections late in the season.
The vaccine lowers infection risk — it works very well
against influenza B — and may also minimize the risk of severe infection.
Studies have shown that flu vaccines work better at protecting
against influenza B or influenza A H1N1 viruses than influenza A H3N2.
It's possible that getting sick with one type of influenza A virus would offer some modest protection against another type of influenza A, but it probably wouldn't give you any protection
against the influenza B virus, Schaffner said.
It was better against the other viruses, at 67 % against H1N1 and 42 %
against influenza B viruses, she said.
Not exact matches
In 1942, after the discovery of
influenza B, a bivalent vaccine, which protected
against influenza A and
influenza B, was produced.
Your baby will be getting the second dose of the 5 - in - 1 injection which protects
against diphtheria, tetanus, whooping cough (pertussis), polio and Hib (haemophilus
influenza type
B).
The Hep
B vaccine (or HBV) protects against the virus that causes hepatitis B; the DTaP vaccine protects against the viruses that cause diphtheria, tetanus, and pertussis (whooping cough); the PCV (pneumococcal vaccine) protects against the cause of bacterial meningitis, pneumonia, and ear infections; the Hib vaccine protects against Haemophilus influenzae type b bacteria (which can also cause bacterial meningitis, pneumonia, or epiglottitis); and the rotavirus oral vaccine protects against a virus that causes the stomach flu
B vaccine (or HBV) protects
against the virus that causes hepatitis
B; the DTaP vaccine protects against the viruses that cause diphtheria, tetanus, and pertussis (whooping cough); the PCV (pneumococcal vaccine) protects against the cause of bacterial meningitis, pneumonia, and ear infections; the Hib vaccine protects against Haemophilus influenzae type b bacteria (which can also cause bacterial meningitis, pneumonia, or epiglottitis); and the rotavirus oral vaccine protects against a virus that causes the stomach flu
B; the DTaP vaccine protects
against the viruses that cause diphtheria, tetanus, and pertussis (whooping cough); the PCV (pneumococcal vaccine) protects
against the cause of bacterial meningitis, pneumonia, and ear infections; the Hib vaccine protects
against Haemophilus
influenzae type
b bacteria (which can also cause bacterial meningitis, pneumonia, or epiglottitis); and the rotavirus oral vaccine protects against a virus that causes the stomach flu
b bacteria (which can also cause bacterial meningitis, pneumonia, or epiglottitis); and the rotavirus oral vaccine protects
against a virus that causes the stomach flu.
Annual flu vaccines are formulated to protect
against one type of
influenza B and two strains of
influenza A, one H3N2 strain and one H1N1 strain.
A team led by Ron Dagan, a pediatric infectious disease specialist at Soroka University Medical Center in Beer - Sheva, Israel, wanted to know if a new pneumococcal vaccine based on tetanus toxoid would change infants» immune responses to the standard regimen of vaccines, including those for diphtheria, tetanus, pertussis (DTP), and Haemophilus
influenzae type
B, which protects
against meningitis.
Legal loopholes Each US state sets its own vaccination policies, and most will not generally allow children to attend public school unless they have been vaccinated
against diphtheria, tetanus and pertussis (whooping cough); hepatitis
B; the Haemophilus
influenzae bacterium; measles, mumps and rubella; polio; and varicella (chicken pox).
Since the most severe infections are caused by
influenza type A and type
B viruses, the available vaccines provide coverage
against these two types.
According to WHO statistics, 300 million people are vaccinated
against the flu each year, receiving an immunization with a cocktail of weakened strains of
influenza A (varieties H3N2 and H1N1), along with the
influenza B virus to protect
against a full infection.
The recommended vaccination schedule was inactivated vaccine
against diphtheria, tetanus, pertussis, polio, and Haemophilus
influenzae type
b (DTaP - IPV - Hib) administered at ages 3, 5, and 12 months; and MMR at age 15 months.
«Given these results in cells and mice, it may be worthwhile to consider that patients receiving, or who may receive, Amphotericin
B - based therapies be appropriately vaccinated
against influenza virus.
On the basis of the current studies as well as previous reports on the use of intradermal immunization
against influenza, hepatitis
B, rabies, and other infectious diseases, 2,3,8 it is becoming clear that use of the intradermal route may at least partially overcome the relatively poor
influenza - specific immune responses seen in certain at - risk populations, particularly the elderly, in whom the immune response in general is known to diminish with age.9 Moreover, in times of shortage, the dose - sparing intradermal approach might be particularly well suited to the young, healthy persons included in the CDC's high - priority group for vaccination, such as health care workers, as well as to younger, otherwise healthy populations in general.
Broadly cross-reactive antibodies dominate the human
B cell response
against 2009 pandemic H1N1
influenza virus infection
«IL - 28
B is a key regulator of
B - and T - Cell vaccine responses
against influenza» by Adrian Egli et al. published in PLOS Pathogens on Thursday 11 December 2014.
The study relates to a particular type of vaccine (killed)
against a particular virus,
influenza, though the findings might hold true for other killed vaccines and for those vaccines consisting only of proteins produced by GM in bacteria, yeast or insect cells,
against diseases such as hepatitis
B (HBV) and human papilloma virus (HPV, the causative agent of cervical cancer).
To assess the impact of maternal Abs on vaccine commonly administered in infancy, Jones et al. (131) examined the relationship between the concentration of Abs
against pertussis, H.
influenzae type
B, tetanus toxoid, and pneumococcal Ags at birth and after primary immunization.
FLULAVAL is an
influenza virus vaccine indicated for active immunization of adults 18 years of age and older
against influenza disease caused by
influenza virus subtypes A and type
B contained in the vaccine.
There have been many scientific studies that point strongly to the effectiveness of Elderberries
against viruses, particularly
Influenza A and
B strains.
In studies that looked at its efficacy
against influenza strains A &
B, Elderberry was found to shorten the duration of the flu from the typical 7 days to 4 days.
The results showed that elderberry syrup is also effective
against both
influenza A and
B virus infections.
Sinovac Biotech Ltd. is biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect
against human infectious diseases including hepatitis A and
B, seasonal
influenza, H5N1 pandemic
influenza and mumps, as well as animal rabies vaccine.
(
b) I found it it highly coincidental that I received a brochure advertising a vaccine for the «new»
influenza (which actually may not protect
against the «old»
influenza) in the very same week the TV announcements were released.
Flublok contains three, full - length, recombinant HA proteins to help protect
against two
influenza virus A strains, H1N1 and H3N2, and one
influenza virus
B strain.
It protects
against three of the most common strains: H1N1 and
Influenza A and
B. It's strongly suggested for young children, the elderly, pregnant women and those with pregnancy, asthma, diabetes, heart and lung disease.